Triplefin LLC – Trademark Portfolio
Entity Type: 16
Triplefin LLC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 6 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include RXHOPE. The owner is based in Cincinnati, OH.
11333 Cornell Park Drive
Cincinnati, OH 45242
Showing of trademarks Trademarks
Trademark Classifications
Triplefin LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Triplefin LLC have?
Triplefin LLC has 10 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 7 cancelled.
What trademark classes does Triplefin LLC file in?
Triplefin LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 38 (Telecommunications). Class 35 covers advertising; business management; business administration; office functions.
What are Triplefin LLC's most well-known trademarks?
Triplefin LLC's registered trademark portfolio includes well-known marks such as RXHOPE. These are among 1 currently registered trademark in the portfolio.
What is Triplefin LLC's trademark registration success rate?
Triplefin LLC has a 10% trademark registration rate, with 1 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.